Global Coronary Atherectomy Devices Market Size By Type (Laser Atherectomy, Orbital Atherectomy), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Coronary Atherectomy Devices Market Report Description

The Global Coronary Atherectomy Devices Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. This growth is primarily attributed to the rising prevalence of coronary artery disease (CAD), increasing geriatric population, and growing preference for minimally invasive cardiovascular procedures. Atherectomy devices are increasingly used in percutaneous coronary interventions (PCI) to remove atherosclerotic plaque, facilitating stent placement and restoring optimal blood flow.

Drivers:

1. Rising Prevalence of Coronary Artery Disease:

CAD remains one of the leading causes of mortality worldwide. The increasing incidence of diabetes, hypertension, and lifestyle-related conditions has intensified the demand for effective coronary interventions, boosting market growth.

2. Shift Towards Minimally Invasive Procedures:

The growing preference for catheter-based interventions over open surgeries has significantly increased the adoption of atherectomy devices due to their precision and shorter recovery times.

3. Technological Advancements:

Innovations such as rotational, orbital, and laser atherectomy devices offer enhanced safety and efficacy. These advances are improving procedural outcomes and expanding the clinical applications of atherectomy.

Restraints:

1. High Procedure and Device Costs:

Despite clinical benefits, the high cost associated with coronary atherectomy procedures and devices may limit adoption, especially in low- and middle-income countries.

2. Risk of Procedural Complications:

Potential complications like vessel perforation, restenosis, and embolization may deter both physicians and patients, constraining market growth.

Opportunity:

1. Untapped Potential in Emerging Markets:

Rapid healthcare infrastructure development and growing healthcare awareness in regions such as Asia-Pacific and Latin America present lucrative opportunities for market players.

2. Integration with Imaging Modalities:

Combining atherectomy with intravascular imaging technologies like OCT and IVUS enhances procedural precision and outcomes, opening avenues for product differentiation and clinical adoption.

Market by System Type Insights:

Rotational Atherectomy Devices accounted for the largest share in 2023, widely used due to their effectiveness in treating heavily calcified lesions. These devices continue to dominate due to their clinical success and ease of use. However, Laser Atherectomy Devices are gaining traction, particularly in complex cases where precision ablation of plaque is crucial.

Market by End-use Insights:

Hospitals remained the dominant end-use segment in 2023, holding over 60% market share. Their comprehensive infrastructure and availability of specialized cardiologists make hospitals the preferred setting for coronary atherectomy procedures. Ambulatory Surgical Centers (ASCs) are projected to witness rapid growth due to their cost-effectiveness and increasing adoption of outpatient coronary interventions.

Market by Regional Insights:

North America led the global market in 2023, driven by the high burden of CAD, well-established healthcare systems, and early adoption of advanced technologies. Asia-Pacific is anticipated to register the fastest growth during the forecast period, supported by increasing healthcare expenditure, rising CAD cases, and improvements in medical infrastructure across countries like China and India.

Competitive Scenario:

Key players in the global coronary atherectomy devices market include Boston Scientific Corporation, Cardiovascular Systems Inc. (CSI), Medtronic plc, Avinger Inc., and Philips N.V. These companies are focusing on strategic mergers, FDA approvals, and technological innovations to solidify their market position.

Key Market Developments:

In 2023, Boston Scientific launched an enhanced version of its rotational atherectomy system with improved crossability for complex lesions.

Medtronic announced clinical trial results in 2024 demonstrating the superiority of its orbital atherectomy device for high-risk patients.

In 2025, CSI expanded into emerging markets by securing regulatory clearance for its flagship atherectomy systems in Latin America and Southeast Asia.

Scope of Work – Global Coronary Atherectomy Devices Market

Report Metric Details

Market Size (2023) USD 1.3 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023–2031) 8.1%

Key Segments By System Type (Rotational, Orbital, Laser), By End-use

Growth Drivers Rise in CAD prevalence, preference for minimally invasive procedures, and technological advancements

Opportunities Expansion in emerging markets, integration with imaging technologies

FAQs:

1) What is the current market size of the Global Coronary Atherectomy Devices Market?

The market size was valued at USD 1.3 billion in 2023.

2) What is the major growth driver of the Global Coronary Atherectomy Devices Market?

The primary growth driver is the rising prevalence of coronary artery disease and the increasing demand for minimally invasive cardiovascular procedures.

3) Which is the largest region during the forecast period in the Global Coronary Atherectomy Devices Market?

North America is expected to maintain its leading position throughout the forecast period.

4) Which segment accounted for the largest market share in Global Coronary Atherectomy Devices Market?

The Rotational Atherectomy Devices segment held the largest market share in 2023.

5) Who are the key market players in the Global Coronary Atherectomy Devices Market?

Key players include Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic plc, Avinger Inc., and Philips N.V.